Deficiency in the production of antibodies to lipids correlates with increased lipid metabolism in severe COVID-19 patients
Description
CONCLUSION: Antibodies to lipids are essential for defense against SARS-CoV-2. Patients with low levels of anti-lipid antibodies have an elevated inflammatory response mediated by lysoglycerophospholipids. These findings provide novel prognostic
